News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Neoadjuvant botensilimab and balstilimab in colorectal cancer
Photo of Dorna Jafari from X
Jun 29, 2024, 11:05

Neoadjuvant botensilimab and balstilimab in colorectal cancer

Smitha Krishnamurthi, Gastrointestinal medical oncologist at Cleveland Clinic, shared on X:

“Neoadjuvant botensilimab (1 dose) and balstilimab (4 doses) resulted in pathologic complete response in 5/9 patients with pMMR colorectal cancer!

Early results but super impressive.”

colorectal cancer

Source: Smitha Krishnamurthi/X

Balstilimab botensilimab cancer Cleveland Clinic colorectal cancer Dorna Jafari ESMOGI24 OncoDaily Oncology Smitha Krishnamurthi
Blog
Jul 1, 2024, 10:01
Stephen Chun: Long-term outcomes of IMRT for locally-advanced lung cancer
Insight
Jul 1, 2024, 09:25
Sylvester cancer expert endorses FDA approval of new drug
Blog
Jul 1, 2024, 09:17
Medigene Reports Results of Annual General Meeting
Blog
Jul 1, 2024, 09:12
Agenus - CTEP has announced the availability of botensilimab, for clinical studies
Blog
Jul 1, 2024, 08:21
Karen Knudsen: MCEDAct creates a pathway to ensure timely Medicare coverage
Blog
Jul 1, 2024, 08:08
CtDNA in early Colorectal cancer
Blog
Jul 1, 2024, 07:57
Raffaele Colombo: TOPO1i ADC after TOPO1i ADC?
Insight
Jul 1, 2024, 07:31
Dan Vahdat: Digital-first cancer care for all
Blog
Jul 1, 2024, 06:50
Am I Doing Enough? - Pat Garcia-Gonzalez
Insight
Jul 1, 2024, 06:22
Partnership with Novartis for over 20 years - The Max Foundation
Insight
Jul 1, 2024, 06:11
Conquer Cancer has awarded more than $11 million to physician-scientists at the ASCO Annual Meeting
Drugs
Jul 1, 2024, 06:09
FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma - Genmab